DeltaWave TVMS™ is an investigational neuromodulation platform under clinical evaluation for its ability to support sleep restoration through distributed autonomic network modulation.

The system delivers ultra-low-intensity, non-contact longitudinal transspinal electromagnetic fields intended to influence distributed spinal-autonomic network timing dynamics without inducing direct neural depolarization.

This structured field exposure is designed to promote coordinated intersegmental timing across autonomic pathways, supporting physiologic conditions associated with stable NREM3 (slow-wave sleep).

In early randomized clinical research, DeltaWave use has been associated with increased slow-wave sleep duration and reduced slow-wave sleep fragmentation — the sleep stage associated with restorative brain processes including glymphatic function, synaptic homeostasis, and metabolic recovery.

Clinical Study Validation
Slow-wave sleep was improved with DeltaWave TVMS Active device use relative to Sham, across three metrics:

➤ 42% increase in slow-wave sleep proportion

➤ 36% increase in slow-wave sleep duration

➤ 72% reduction in slow-wave sleep fragmentation